Groundbreaking studies are a promise of ABX-IL8, this selective compound designed to precisely block interleukin-8 (IL-8), the important cytokine involved in several chronic conditions . In contrast with broad-spectrum therapies, ABX-IL8 offers a highly mechanism to reduce IL-8 activity , possibly resulting to better efficacy in conditions such… Read More